BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12803844)

  • 1. Retrospective analysis of abnormal 24-h urinary free catecholamine concentration in screening for phaeochromocytoma.
    Idris IR; Hill R; Sands KA; Thomson GA
    Ann Clin Biochem; 2003 May; 40(Pt 3):283-5. PubMed ID: 12803844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary catecholamines and the diagnosis of phaeochromocytoma in Auckland.
    McNeil AR; Woollard GA
    N Z Med J; 1997 Sep; 110(1051):331-3. PubMed ID: 9323371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The catecholamine concentration in central veins of hypertensive patients--an aid not without problems in locating phaeochromocytoma.
    Collste P; Brismar B; Alveryd A; Björkhem I; Hårdstedt C; Svensson L; Ostman J
    Acta Chir Scand Suppl; 1986; 530():67-71. PubMed ID: 3460293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the usefulness for measuring catecholamines and their principle metabolites in the diagnosis of pheochromocytoma].
    Wocial B; Januszewicz W; Gryglas P; Januszewicz A; Feltynowski T; Lapiński M
    Przegl Lek; 1997; 54(11):793-8. PubMed ID: 9501691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal catecholamine production in a patient with a paroxysmally secreting phaeochromocytoma.
    Sinclair D; Shenkin A; Lorimer AR
    Ann Clin Biochem; 1991 Jul; 28 ( Pt 4)():417-9. PubMed ID: 1892355
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship between plasma renin activity and urinary catecholamines in various types of hypertension.
    Horký K; Kopecká J; Greogorová I; Dvoráková J
    Endokrinologie; 1976 Jul; 67(3):331-42. PubMed ID: 976208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the clonidine suppression test in the diagnosis of phaeochromocytoma.
    McHenry CM; Hunter SJ; McCormick MT; Russell CF; Smye MG; Atkinson AB
    J Hum Hypertens; 2011 Jul; 25(7):451-6. PubMed ID: 20811397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No correlation between phaeochromocytoma catecholamine secretion and granule ultrastructure.
    Mihai R; Wong NA; Luckett M; Sheffield E; Farndon JR
    Br J Surg; 1998 Dec; 85(12):1681-5. PubMed ID: 9876074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Catecholamines in the cardiovascular expression of pheochromocytoma. II--Study of free urinary catecholamines in 14 pheochromocytomas. Classification of pheochromocytomas according to type of secretion].
    Fontaine P; Wemeau JL; Verlet E; Racadot-Leroy N; Decaudaveine B; Proye C; Lefebvre J; Fossati P
    Ann Endocrinol (Paris); 1986; 47(5):380-8. PubMed ID: 3827193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Urinary Catecholamine Excretion and Urine Volume.
    Haap M; Blaschka F; Lehmann R; Hoyer A; Müssig K
    Horm Metab Res; 2019 Aug; 51(8):531-538. PubMed ID: 31174227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamine excretion and circadian blood pressure profile in patients with pheochromocytoma.
    Dabrowska E; Lewandowski J; Jedrusik P; Symonides B; Wocial B; Lapinski M; Gaciong Z
    Ann N Y Acad Sci; 2006 Aug; 1073():79-85. PubMed ID: 17102074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Measurement of platelet catecholamine content for the diagnosis of pheochromocytoma with intermittent hypertension].
    Plouin PF; Chatellier G; Billaud-Mesguich E; Comoy E; Duclos JM; Ménard J
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):812-5. PubMed ID: 3116976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phaeochromocytoma--a laboratory experience.
    Tormey WP; FitzGerald RJ
    Ir J Med Sci; 1995; 164(2):142-5. PubMed ID: 7607841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pheochromocytoma--rare and often undiagnosed condition].
    Manhem P; Wahrenberg H
    Lakartidningen; 2002 Mar; 99(14):1585-9. PubMed ID: 12025214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparate urinary catecholamine patterns in secondary hypertension due to unique sequential development of pheochromocytoma and neuroblastoma.
    Amodeo C; Perez J; Sturgill BC; Turner SM; Atuk NO
    Arch Pathol Lab Med; 1989 Jul; 113(7):800-2. PubMed ID: 2742460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.
    Davidson DF; Grosset K; Grosset D
    Ann Clin Biochem; 2007 Jul; 44(Pt 4):364-8. PubMed ID: 17594783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamine determination in sequential urine voiding: a method for detecting pheochromocytoma in patients without elevated urinary catecholamines.
    Enat R; Greenberg A; Zinder O
    Isr J Med Sci; 1991 Jan; 27(1):12-6. PubMed ID: 1995493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical tests for diagnosis of phaeochromocytoma: urinary versus plasma determinations.
    Plouin PF; Duclos JM; Menard J; Comoy E; Bohuon C; Alexandre JM
    Br Med J (Clin Res Ed); 1981 Mar; 282(6267):853-4. PubMed ID: 6783201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart rate variability before sudden blood pressure elevations or complex cardiac arrhythmias in phaeochromocytoma.
    Dabrowska B; Dabrowski A; Pruszczyk P; Skrobowski A; Wocial B
    J Hum Hypertens; 1996 Jan; 10(1):43-50. PubMed ID: 8642190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Excretion of free catecholamines in relation to age, sex and blood pressure].
    Lehmann M; Spöri U; Keul J
    Z Kardiol; 1985 May; 74(5):294-7. PubMed ID: 4013464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.